Hexagon Capital Partners’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8
Closed -$102 1468
2023
Q3
$102 Hold
8
﹤0.01% 1362
2023
Q2
$114 Hold
8
﹤0.01% 1379
2023
Q1
$119 Sell
8
-53
-87% -$803 ﹤0.01% 1383
2022
Q4
$906 Buy
61
+8
+15% +$131 ﹤0.01% 1217
2022
Q3
$1K Buy
+53
New +$1.07K ﹤0.01% 1222

Other funds holding MD

Hexagon Capital Partners's MD Position: Q4 2023 in Review

Hexagon Capital Partners sold out of Pediatrix Medical (MD) in Q4 2023, closing a stake of 8 shares — an estimated $102 sold.

Hexagon Capital Partners first reported a position in MD in Q3 2022 and held it in 5 quarters. The position peaked at $1K in Q3 2022. 223 funds tracked by Wall St. Rank hold MD as of Q4 2023.

  • Hexagon Capital Partners reported no remaining Pediatrix Medical position as of Q4 2023 after selling out during the quarter.
  • Hexagon Capital Partners sold 8 Pediatrix Medical shares in Q4 2023, an estimated $102.
  • Hexagon Capital Partners first reported a position in Pediatrix Medical in Q3 2022 and held it in 5 quarters.
  • Hexagon Capital Partners's Pediatrix Medical position peaked at $1K in Q3 2022.
  • 223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2023.

Based on Hexagon Capital Partners's 13F filing for Q4 2023, filed 5 Feb 2024.